Advances in the Development of New Antituberculotic Agents in the Group of MonocyclicSix-Membered Heterocyclic Compounds with a Larger Number of Nitrogen Atoms
Authors:
K. Waisser; P. Holý; O. Bureš
Authors‘ workplace:
Katedra anorganické a organické chemie Farmaceutické fakulty Univerzity Karlovy
Published in:
Čes. slov. Farm., 2000; , 268-277
Category:
Overview
Tuberculosis and other mycobacterial diseases are considered to be one of the major health problemsat present. Since 1985, and in particular in the 1990s, a search for new structures of antimycobac-terial substances has been one of the priorities of chemotherapeutic research. Pyrazine derivativeshave always attracted the interest of research laboratories searching for new chemotherapeuticagents against tuberculosis. The present review paper, based on the journal Chemical Abstractsand original papers, surveys the attempts of the laboratories searching for new antituberculoticagents in the region of six-membered heterocyclic pyrimidine, pyrazine, and triazines compoundsin recent fifteen years.
Key words:
tuberculostatics – pyrimidine – pyrazine – triazines – mycobacteria
Labels
Pharmacy Clinical pharmacologyArticle was published in
Czech and Slovak Pharmacy
2000 Issue 6
Most read in this issue
- Kojic Acid and Its Derivatives as Potential Drugs
- Chalcones and Their Heterocyclic Analogues as Potential Therapeutic Agents of Bacte-rial Diseases
- Allergic Contact Dermatitis Due to Propolis
- Advances in the Development of New Antituberculotic Agents in the Group of MonocyclicSix-Membered Heterocyclic Compounds with a Larger Number of Nitrogen Atoms